Publications by authors named "Ravenscroft N"

SUMMARY (the "pneumococcus") is a significant human pathogen. The key determinant of pneumococcal fitness and virulence is its ability to produce a protective polysaccharide (PS) capsule, and anti-capsule antibodies mediate serotype-specific opsonophagocytic killing of bacteria. Notably, immunization with pneumococcal conjugate vaccines (PCVs) has effectively reduced the burden of disease caused by serotypes included in vaccines but has also spurred a relative upsurge in the prevalence of non-vaccine serotypes.

View Article and Find Full Text PDF
Article Synopsis
  • The polysaccharide capsule of pneumococcus protects the bacteria from the host immune system and is the main target for existing vaccines; however, the effectiveness of these vaccines can be compromised by variations in the capsule structure.
  • Recent research has identified a new capsule type, 20C, which differs from the previously known B subtype due to gene inactivation affecting the capsule structure.
  • There is a need for advanced genetic screening and bioinformatics to monitor mutations in capsule-related genes, which could influence vaccine effectiveness and the emergence of new capsule variants.
View Article and Find Full Text PDF

Extracellular polysaccharides are crucial components for biofilm development. Although Bacillus subtilis is one of the most characterized Gram-positive biofilm model system, the structure-function of its exopolysaccharide, EpsA-O, remains to be elucidated. By combining chemical analysis, NMR spectroscopy, rheology, and molecular modeling, high-resolution data of EpsA-O structure from atom to supramolecular scale was obtained.

View Article and Find Full Text PDF

(Kp) is a Gram-negative bacterium, and a leading cause of neonatal sepsis in low- and middle-income countries, often associated with anti-microbial resistance. Two types of polysaccharides are expressed on the Kp cell surface and have been proposed as key antigens for vaccine design: capsular polysaccharides (known as K-antigens, K-Ags) and O-antigens (O-Ags). Historically, Kp has been classified using capsule serotyping and although 186 distinct genotypes have been predicted so far based on sequence analysis, many structures are still unknown.

View Article and Find Full Text PDF

Introduction: Different serovars of Salmonella enterica cause systemic diseases in humans including enteric fever, caused by S. Typhi and S. Paratyphi A, and invasive nontyphoidal salmonellosis (iNTS), caused mainly by S.

View Article and Find Full Text PDF

Background: In care home research, residents are rarely included in patient and public involvement and engagement (PPIE) despite their lived experiences of day-to-day care. This paper reports on a novel approach to PPIE, developed in response to Covid-19, and utilised in a large UK-based study focused on care homes. PPIE sessions were facilitated on behalf of the research team by Activity Providers (APs) already working within the care homes.

View Article and Find Full Text PDF

(the pneumococcus) is a bacterial pathogen with the greatest burden of disease in Asia and Africa. The pneumococcal capsular polysaccharide has biological relevance as a major virulence factor as well as public health importance as it is the target for currently licensed vaccines. These vaccines have limited valency, covering up to 23 of the >100 known capsular types (serotypes) with higher valency vaccines in development.

View Article and Find Full Text PDF

A selective and sensitive method was evaluated for quantitation of meningococcal X (Men X) polysaccharide in pentavalent meningococcal A, C, W, Y and X conjugate vaccine using different acid hydrolysis conditions like HCl, TFA, HF, HF-TFA, and HF-HCl. High-performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) using CarboPac PA10 column was used to identify the hydrolyzed products based on retention time and its comparison with monosaccharide standards. Complete release of glucosamine (GlcN) from Men X in monovalent bulk and pentavalent vaccine samples was achieved using HF hydrolysis at 80 °C for 2 h.

View Article and Find Full Text PDF

Determining the safety, antigenicity, and immunogenicity by in vitro and in vivo studies is a prerequisite for the development of new vaccines. And this study investigated it for a vaccine made from Streptococcus pneumoniae serotypes 2, 5, 12F, 18C, and 22F. The crude CPS was purified and partially depolymerized by conventional and trifluoroacetic acid methods.

View Article and Find Full Text PDF

Soil salinization is a major environmental stressor hindering global crop production. Hydropriming has emerged as a promising approach to reduce salt stress and enhance crop yields on salinized land. However, a better mechanisitic understanding is required to improve salt stress tolerance.

View Article and Find Full Text PDF

Pasteurella multocida, an encapsulated gram-negative bacterium, is a significant veterinary pathogen. The P. multocida is classified into 5 serogroups (A, B, D, E, and F) based on the bacterial capsular polysaccharide (CPS), which is important for virulence.

View Article and Find Full Text PDF

is an encapsulated gram-negative bacterium and a significant human pathogen The capsular polysaccharide (CPS) is essential for virulence and a target antigen for vaccines. Although widespread introduction of pneumococcal conjugate vaccines (PCVs) has significantly reduced disease, the prevalence of non-vaccine serotypes has increased. On the basis of the CPS, serogroup 10 comprises four main serotypes 10A, 10B, 10C, and 10F; as well as the recently identified 10D.

View Article and Find Full Text PDF

A high-quality and cost-effective purification procedure is one of the most important requirements for manufacturing glycoconjugate vaccines. The goal of the present work was to devise a method for removing impurities such as protein and nucleic acid from Streptococcus pneumoniae serotype 2 capsular polysaccharides (CPS). The use of hydrogen peroxide for the reduction of impurities of crude CPS was investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Salmonella enterica serovar Typhimurium is a major cause of invasive disease in sub-Saharan Africa and exhibits high antimicrobial resistance, with no licensed vaccine currently available.
  • O-antigen-based vaccine candidates are being developed, but recent data show an increase in isolates without the critical O:5 antigen, raising concerns about the effectiveness of these vaccines.
  • This study sequenced 354 Salmonella Typhimurium isolates from the Democratic Republic of the Congo and found that the loss of the O:5 epitope is mainly due to genetic recombination, indicating an evolutionary shift in the bacterial population under pressure from invasive disease.
View Article and Find Full Text PDF
Article Synopsis
  • Pneumococcal polysaccharide conjugate vaccines (PCVs) provide protection through antibodies that can effectively target specific serotypes of Streptococcus pneumoniae, particularly those covered by the vaccine.
  • The prevalence of serotypes 15B, 15A, and 15C has increased after the introduction of a 13-valent PCV, prompting the need for a method to differentiate these closely related serotypes using whole-genome sequencing.
  • A study found that a 20-valent PCV induced strong immune responses against serotype 15B and cross-reactive responses against 15C but negligible responses against 15A, suggesting varying effectiveness based on polysaccharide structure.
View Article and Find Full Text PDF

Generalized modules for membrane antigens (GMMA) are exosomes released from engineered Gram-negative bacteria and represent an attractive vaccine platform for the delivery of the O-Antigen (OAg), recognized as the key target for protective immunity against several pathogens such as Shigella. Shigella is a major cause of disease in Low- and Middle-Income countries and the development of a vaccine needs to deal with its large serotypic diversity. All S.

View Article and Find Full Text PDF

Covalent modification of the oncogenic mutant epidermal growth factor receptor (EGFR) by small molecules is an efficient strategy for achieving an enhanced and sustained pharmacological effect in the treatment of non-small-cell lung cancer. NSP-037 (), an irreversible inhibitor of the L858R/T790M double-mutant EGFR (EGFR) using α-chlorofluoroacetamide (CFA) as a novel warhead, has seven times the inhibition selectivity for EGFR over the wild type (EGFR), as compared to clinically approved osimertinib (). Here, we employ multiple computational approaches to elucidate the mechanism underlining this improved selectivity, as well as the effect of CFA on the selectivity enhancement of inhibitor over .

View Article and Find Full Text PDF

Partial depolymerization of bacterial capsular polysaccharides (CPS) is an essential process carried out before its use as an antigenic preparation in a vaccine industry. Choice of CPS depolymerization methods depends on the process robustness, reproducibility, yield, retention of CPS bioactivity, etc. Partial depolymerization methods based on chemicals, enzymes, mechanical, thermal, etc.

View Article and Find Full Text PDF

Although the quality of current additive all-atom force fields for carbohydrates has been demonstrated in many applications, occasional significant differences reported for the hydrodynamic behavior of specific polysaccharides modeled with different force fields is a cause for concern. In particular, irreversible conformational collapse has been noted for some polysaccharide simulations with the GLYCAM06j force field. Here, we investigate the cause of this phenomenon through comparative simulations of a range of saccharides with both the GLYCAM06j and the CHARMM36 carbohydrate force fields.

View Article and Find Full Text PDF

Listeria innocua is genetically closely related to the foodborne human pathogen Listeria monocytogenes. However, as most L. innocua strains are non-pathogenic, it has been proposed as a surrogate organism for determining the efficacy of antimicrobial strategies against L.

View Article and Find Full Text PDF

Background: Calcium oxalate (CaOx) kidney stone disease is common in South African whites (W) but is rare in the black population (B). The possible role of endogenous urinary glycosaminoglycans (GAGs) has not been previously investigated in this context.

Aim: To determine concentration, composition, structure and CaOx crystal-inhibiting properties of this group of compounds in ultrafiltered urine of healthy subjects from both groups.

View Article and Find Full Text PDF

Haemophilus influenzae is a leading cause of meningitis disease and mortality, particularly in young children. Since the introduction of a licensed conjugate vaccine (targeting the outer capsular polysaccharide) against the most prevalent serotype, Haemophilus influenzae serotype b, the epidemiology of the disease has changed and Haemophilus influenzae serotype a is on the rise, especially in Indigenous North American populations. Here we apply molecular modeling to explore the preferred conformations of the serotype a and b capsular polysaccharides as well as a modified hydrolysis resistant serotype b polysaccharide.

View Article and Find Full Text PDF

Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against serogroups A, C, Y, W and X. MenA and X polysaccharides are conjugated to tetanus toxoid (TT) while MenC, Y and W polysaccharides are conjugated to recombinant cross reactive material 197 (rCRM), a non-toxic genetic variant of diphtheria toxin. This study describes quality control testing performed by the manufacturer, Serum Institute of India Private Limited (SIIPL), and the independent control laboratory of the U.

View Article and Find Full Text PDF

The pathogenic bacterium is a leading cause of diarrheal disease and mortality, disproportionately affecting young children in low-income countries. The increasing prevalence of antibiotic resistance in necessitates an effective vaccine, for which the bacterial lipopolysaccharide O-antigen is the primary target. serotype 6 has been proposed as a multivalent vaccine component to ensure broad protection against .

View Article and Find Full Text PDF
Article Synopsis
  • Extraintestinal pathogenic Escherichia coli (ExPEC) leads to various infections, with rising multidrug resistance posing treatment challenges, making them a concern for global health.
  • A study focused on urine isolates from Switzerland identified a high prevalence of the O25B serotype linked to a new E. coli clone, leading to the development of an O25B glycoconjugate vaccine.
  • The vaccine was engineered by integrating the O antigen into an E. coli strain and conjugating it to a carrier protein, confirming the structure for potential future use in a multivalent vaccine against ExPEC.
View Article and Find Full Text PDF